- •DeepSeek V4 Flash argues HOLD because The original LONG thesis at $314.00 remains intact. Price has recovered +3.4% from entry and is in a healthy pullback to the 4h SMA20 ($316.54) after attempting $330, with improving MACD structure and rising RSI from oversold levels. The broad equity regime is bullish, the China sales catalyst is driving recovery, and the $337 target is still achievable within the remaining 10-day horizon with the effective stop at $314.00 providing a well-defined risk boundary.
- •What changed: Price pulled back from $330 area to $324.93, testing the 4h SMA20 support. Volume has been depressed (z-score -2.07). TSLA is underperforming the consumer discretionary sector today (-0.67% vs XLY +0.80%). The 4h RSI has ticked down slightly (-1.39 over 3 bars) but MACD histogram remains positive and rising.
The original LONG thesis at $314.00 remains intact. Price has recovered +3.4% from entry and is in a healthy pullback to the 4h SMA20 ($316.54) after attempting $330, with improving MACD structure and rising RSI from oversold levels. The broad equity regime is bullish, the China sales catalyst is driving recovery, and the $337 target is still achievable within the remaining 10-day horizon with the effective stop at $314.00 providing a well-defined risk boundary.
TSLA's original thesis remains intact, supported by a fresh catalyst (strong China sales) and improving technical momentum. The stock is recovering toward the $337.24 target, with no evidence of invalidation or breach of critical support levels. The broader market regime is bullish, providing additional confirmation for the trade.
The position is +3.4% and above entry, holding above 4h SMA20 ($316.54) with 4h MACD histogram positive and rising and 1day RSI turning up off depressed levels, indicating momentum repair rather than breakdown. A fresh China-sales catalyst and Musk's denial of negative China-spinoff reporting are pushing shares toward $330, keeping the original long path to the $337 target alive with only ~3.7% remaining and no immediate event risk in a confirmed bullish equity regime.
No model argued for EXIT.
- →Price loses the 4h SMA20 ($316.54) and effective stop ($314.00), breaking the pullback structure and confirming the recovery attempt has failed, invalidating the original thesis path to $337.
Individual Model Review
The position is +3.4% and above entry, holding above 4h SMA20 ($316.54) with 4h MACD histogram positive and rising and 1day RSI turning up off depressed levels, indicating momentum repair rather than breakdown. A fresh China-sales catalyst and Musk's denial of negative China-spinoff reporting are pushing shares toward $330, keeping the original long path to the $337 target alive with only ~3.7% remaining and no immediate event risk in a confirmed bullish equity regime.
The position is +3.4% and above entry, holding above 4h SMA20 ($316.54) with 4h MACD histogram positive and rising and 1day RSI turning up off depressed levels, indicating momentum repair rather than breakdown. A fresh China-sales catalyst and Musk's denial of negative China-spinoff reporting are pushing shares toward $330, keeping the original long path to the $337 target alive with only ~3.7% remaining and no immediate event risk in a confirmed bullish equity regime.
▼ Click to expandTSLA remains far below both the 1day SMA20 ($351.81) and SMA50 ($385.03) with a negative daily MACD, a recent Q2 EPS miss (-38.9% surprise), and an extreme valuation (P/E 286). The traded symbol is diverging lower from a green consumer-discretionary sector (XLY +0.80% vs TSLA -0.67%), and depressed volume plus a coincident $337 resistance/target wall argue the remaining upside is capped and could reverse toward the $314 effective stop.
▼ Click to expandThe original LONG thesis at $314.00 remains intact. Price has recovered +3.4% from entry and is in a healthy pullback to the 4h SMA20 ($316.54) after attempting $330, with improving MACD structure and rising RSI from oversold levels. The broad equity regime is bullish, the China sales catalyst is driving recovery, and the $337 target is still achievable within the remaining 10-day horizon with the effective stop at $314.00 providing a well-defined risk boundary.
The original LONG thesis at $314.00 remains intact. Price has recovered +3.4% from entry and is in a healthy pullback to the 4h SMA20 ($316.54) after attempting $330, with improving MACD structure and rising RSI from oversold levels. The broad equity regime is bullish, the China sales catalyst is driving recovery, and the $337 target is still achievable within the remaining 10-day horizon with the effective stop at $314.00 providing a well-defined risk boundary.
▼ Click to expandThe position should be closed because TSLA is showing idiosyncratic weakness today (-0.67%) while the consumer discretionary sector (XLY) is up +0.80%, indicating the stock is not participating in the broad rally. Volume is depressed (z-score -2.07), suggesting lack of conviction behind the recovery. The 1-day RSI at 38.49 is still in bearish territory, and the 4h RSI is falling, signaling momentum may be stalling before reaching the $337 target.
▼ Click to expandTSLA's original thesis remains intact, supported by a fresh catalyst (strong China sales) and improving technical momentum. The stock is recovering toward the $337.24 target, with no evidence of invalidation or breach of critical support levels. The broader market regime is bullish, providing additional confirmation for the trade.
TSLA's original thesis remains intact, supported by a fresh catalyst (strong China sales) and improving technical momentum. The stock is recovering toward the $337.24 target, with no evidence of invalidation or breach of critical support levels. The broader market regime is bullish, providing additional confirmation for the trade.
▼ Click to expandTSLA could be closed if it fails to reclaim the $337.24 resistance level and breaks below the $297.38 support, invalidating the original breakout thesis. Additionally, if the broader market regime shifts bearish or cross-asset divergences widen, the risk/reward profile may deteriorate.
▼ Click to expandRun Summary
Intraday discovery triggered reanalysis on TSLA. Verdict: HOLD (0/3 EXIT). Conviction: 90.